started · updated
Broermann Medical Innovation Award 2026 honors metabolic disease researchers
Professors Svetlana Mojsov, Richard DiMarchi, and Matthias H. Tschöp have been awarded the 2026 Broermann Medical Innovation Award for their research into metabolic diseases and obesity therapies. The award, which is endowed with a total of one million euros, was presented by Hessian Minister-President Boris Rhein at the Hessian State Chancellery in Wiesbaden, Germany.
The laureates were recognized for fundamental work that enabled modern GLP-1-based therapies used to treat obesity and diabetes. The award was established by Dr. Bernard große Broermann, the founder of the Asklepios Kliniken Group.
Entities
Asklepios Kliniken Group · Boris Rhein · Matthias H. Tschöp · Richard DiMarchi · Svetlana Mojsov
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 3 SOURCES] The award was endowed by Dr. Bernard große Broermann, founder of the Asklepios Kliniken Group. livenews.co.nz · businessintelligence.mo · libyanewswire.com
- [● 3 SOURCES] Hessian Minister-President Boris Rhein presented the award at the Hessian State Chancellery. livenews.co.nz · businessintelligence.mo · libyanewswire.com
- [● 3 SOURCES] The Broermann Medical Innovation Award is endowed with a total of one million euros. livenews.co.nz · businessintelligence.mo · libyanewswire.com
- [● 3 SOURCES] The research contributed to enabling modern GLP-1-based therapies against obesity and diabetes. livenews.co.nz · businessintelligence.mo · libyanewswire.com
- [● 3 SOURCES] Prof. Svetlana Mojsov, Prof. Dr. Richard DiMarchi, and Prof. Dr. Dr. h. c. Matthias H. Tschöp were awarded the Broermann Medical Innovation Award 2026. livenews.co.nz · businessintelligence.mo · libyanewswire.com